Diluted Share Count and Equity Value in M&A Transactions

When a buyer offers $42.00 per share for a publicly traded target, multiplying that price by the basic shares outstanding in the financial statements is a starting point, not a complete equity value. In-the-money options, restricted stock units, performance awards, and convertible securities each add incremental shares — and incremental dollars — to the true cost. Getting the diluted share count wrong means getting the equity value wrong, which means getting every multiple derived from it wrong.

The proxy statement (DEF 14A) for any public-company M&A transaction includes an explicit equity value calculation that shows every component. Reading it first and then verifying the inputs is better than building the count from scratch and hoping it matches. When you understand how each component works, you can spot an error in the disclosed calculation just as quickly as you can catch your own.

Why basic shares understate equity value

Basic shares outstanding is the count that appears on the face of the target’s balance sheet and on the cover page of quarterly and annual reports. It does not include any contingent or potentially dilutive instruments.

Financial statements also report a diluted earnings-per-share figure using the treasury stock method, but that calculation uses the average market price of the stock over the reporting period, not an acquisition price. Since the offer price in a transaction is typically set at a premium to the unaffected share price, more instruments become dilutive at the offer price than they were during the reporting period. A practitioner who takes the financial-statement diluted share count and applies it to an acquisition may still be understating equity value — because the dilution was computed at a lower reference price than the offer.

The correct approach is to recompute the diluted share count using the acquisition offer price as the reference.

The treasury stock method

Options and warrants — rights to purchase shares at a defined exercise price — are dilutive when the exercise price falls below the reference price (here, the offer price per share). The treasury stock method (TSM), described in ASC 260-10-45, determines the net incremental shares as follows:

Net dilutive shares = options outstanding − (exercise proceeds ÷ offer price)

Where:

Options outstanding is the number of option shares in the tranche
Exercise proceeds = options outstanding × exercise price per share
Offer price is the per-share cash consideration to all shareholders

The logic: when the options are exercised, the company receives cash equal to the exercise price. In the theoretical TSM framework, that cash is used to repurchase shares at the offer price, offsetting some of the gross dilution. The net incremental shares are what remain after that notional buyback.

Example. 600,000 options with an average exercise price of $18.00; offer price $42.00 per share.

Input	Amount
Options outstanding	600,000
Total exercise proceeds	600,000 × $18.00 = $10,800,000
Notional shares repurchased at offer price	$10,800,000 ÷ $42.00 = 257,143
Net dilutive shares	600,000 − 257,143 = 342,857

These 342,857 shares are added to the basic share count. The option holder’s cash payment partially offsets the dilution.

Options whose exercise price exceeds the offer price are out-of-the-money: a holder would not exercise them for a net loss, and they contribute no dilution. Do not include them.

The same calculation applies to warrants.

Restricted stock units (RSUs)

RSUs are not options — the holder receives shares outright upon vesting, without paying an exercise price. Because there are no exercise proceeds, the treasury stock method does not apply. Each vesting RSU adds one full share.

In M&A transactions, most RSU award agreements contain change-of-control acceleration provisions: unvested RSUs vest automatically at the closing of a qualifying transaction. When that happens, each outstanding unvested RSU that is accelerated is treated as a full issued share and included in the equity value calculation at the offer price.

The mechanics appear in two places:

The individual award agreements (incorporated by reference in the target’s equity plan, typically attached to its most recent proxy statement or filed as an exhibit to Form 10-K)
The merger agreement, which specifies the treatment of each outstanding equity award — including whether unvested RSUs accelerate (“single-trigger”), accelerate only upon a subsequent termination of employment (“double-trigger”), or convert into rights to receive consideration in the surviving entity without acceleration

Do not assume single-trigger acceleration applies to all unvested RSUs. Some plans use double-trigger vesting; under double-trigger, awards that are assumed or substituted in the transaction do not vest at closing unless the employee is subsequently terminated. Double-trigger awards that remain outstanding and unvested at close are typically excluded from the consideration calculation. Read the merger agreement treatment for each award type before constructing the share count.

Performance stock units (PSUs)

PSUs vest based on meeting a defined performance condition — total shareholder return versus a benchmark, revenue growth, EBITDA margin, or a similar metric. The number of shares ultimately issued depends on the performance outcome, which creates a range (from zero to a maximum) rather than a fixed share count.

M&A transactions resolve this uncertainty through the merger agreement’s specified treatment. Common approaches include:

Vest at target. Outstanding PSUs vest at the target performance level (the “100% achievement” count), regardless of actual performance-to-date at close.
Vest at maximum. Outstanding PSUs vest at the maximum achievement level.
Vest pro-rated. PSUs that are mid-performance-period vest at a pro-rated portion of the target or maximum count based on elapsed time in the performance period.
Convert to time-based RSUs. The PSU converts to a time-based RSU at a specified share count, and then follows the RSU treatment described above.

For the equity value calculation, use the specific count the merger agreement specifies for the treatment method. If the proxy states that all outstanding PSUs will be settled at-target at the offer price upon close, include the at-target share count for all outstanding PSUs. If the merger agreement is ambiguous or silent on a specific tranche, document the gap rather than estimating it.

Convertible notes and convertible preferred equity

Convertible instruments can be settled in shares (diluting equity holders) or in cash (making the instrument a debt-like item in the EV bridge). The M&A treatment determines which applies.

Equity settlement (conversion at close). If the merger agreement provides that convertible notes convert to shares at close, the converted shares are included in the diluted count. The conversion ratio — specified in the note indenture — determines how many shares each note converts into. Include these conversion shares in the numerator of the equity value calculation and remove the note from the net debt side of the EV bridge.

Cash settlement. If the acquirer cash-settles the convertible at the conversion value (offer price × conversion ratio), the payment is economically equivalent to redeeming the note at a premium to face. This amount belongs in the EV bridge as a debt-like item — not in the equity share count. The note has been retired for cash, not converted to equity. Record the face value, the conversion premium paid, and the total settlement amount in your transaction documentation.

Repayment at par. If the convertible is repaid at face value (typically the case when a note is out-of-the-money, i.e., the conversion value falls below par), treat it as regular financial debt in the net debt component of the EV bridge. No incremental shares.

Convertible preferred equity follows similar logic: preferred that converts to common at close contributes conversion shares to the diluted count; preferred that is redeemed for cash or assumed as a preferred obligation is a non-equity claim in the EV bridge.

The indenture (filed as Exhibit 4.x to the Form 8-K at the note’s issuance), the merger agreement’s treatment of indebtedness section, and the proxy statement’s consideration summary all provide disclosure about which conversion path applies.

Where to find the inputs in public filings

For any public-company M&A transaction, the proxy statement is the primary source for the equity value calculation.

The proxy’s merger consideration section typically presents a table that reconciles:

Basic shares outstanding at or near the record date
Net dilutive shares from in-the-money options and warrants (by tranche)
Unvested RSUs (accelerating at close)
PSUs (at the agreed measurement level)
Convertible security conversion shares (if equity-settled)
Total shares for consideration purposes
× Offer price per share
= Total equity consideration

Use this stated total as your cross-check. If you reconstruct the count from constituent disclosures and arrive at a different number, investigate before using the transaction in your precedent set. Discrepancies commonly arise from using a different share count date (the proxy may use a date between announcement and the proxy filing date rather than the announcement date itself), from misclassifying double-trigger RSUs as single-trigger, or from handling a partially-in-the-money convertible incorrectly.

Source filings for individual inputs:

Basic shares outstanding. The balance sheet header or “Shares Outstanding” table in the most recent 10-K or 10-Q before announcement. Also on the cover page of the proxy statement.
Options and warrants. The equity award footnote in the annual report (10-K). This discloses the number of shares subject to options, the range and weighted average of exercise prices, and the remaining term. Identify which tranches are in-the-money relative to the offer price and apply TSM to each.
RSUs and PSUs. The same equity award footnote shows the unvested count and vesting schedule. The merger agreement specifies the treatment. Some proxies reproduce the full computation in the merger consideration section; others reference the award plan.
Convertible notes. The debt footnote in the 10-K or 10-Q and the original indenture (Exhibit 4.x to the Form 8-K at issuance) disclose the conversion ratio, the par amount outstanding, and any interest make-whole features triggered on conversion.
Closing verification. The Form 8-K filed at closing (Item 2.01) states the aggregate consideration paid, which can be used to confirm that the share count and equity value you calculated match what was actually delivered.

The SEC filing map for M&A deal terms documents how to navigate EDGAR for each of these filing types.

Common errors

Using basic shares from the balance sheet. The balance sheet reports shares issued, which includes treasury shares (repurchased but not retired shares held by the company). Treasury shares are not outstanding and are not entitled to merger consideration. Subtract treasury shares from issued shares to get the correct basic outstanding count. The cover page of the proxy statement typically states the shares outstanding directly.

Applying the financial-statement diluted share count directly. As described above, the TSM denominator in the financial statements uses the average market price, not the offer price. Recompute using the offer price to capture the full in-the-money dilution at the acquisition price.

Including out-of-the-money options. Only options whose exercise price falls below the offer price are dilutive. Options with exercise prices above the offer price are worthless in a cash acquisition and should be excluded.

Assuming single-trigger acceleration for all RSUs. Double-trigger awards vest only if the employee is terminated after close, not at close itself. Including unvested double-trigger RSUs that were assumed or substituted inflates the equity value.

Treating PSUs at maximum when at-target applies. The merger agreement specifies the settlement level. Using maximum when the agreement specifies at-target overstates the share count. Read the specific terms rather than defaulting to the more conservative or more aggressive assumption.

Adding convertible notes as equity when they are cash-settled. If the acquirer writes a check to retire the convertible at its conversion value, that payment is a cash outflow — a component of the acquisition’s total cost that belongs in the EV bridge, not as incremental equity shares.

Per-transaction documentation checklist

For each public-company transaction in a precedent set:

Basic shares outstanding: source filing, balance sheet date, and whether treasury shares were subtracted
Options and warrants: count, exercise price tranches, which tranches are in-the-money at the offer price, TSM output per tranche
RSUs: unvested count, vesting trigger (single-trigger at close, or double-trigger requiring subsequent termination); count included in equity value calculation
PSUs: outstanding count, merger agreement settlement level (at-target, maximum, pro-rated), count included
Convertibles: face amount, conversion ratio, settlement method (equity conversion vs. cash settlement at conversion value vs. par repayment), treatment in equity value or EV bridge
Total diluted share count: reconciled to the proxy statement’s stated total or documented if proxy was not yet filed at the time of your analysis
Equity value: basic shares × offer price + incremental dilutive value, labeled as reported (taken from proxy) or calculated (your reconstruction)
Discrepancies: any difference between your count and the proxy’s stated count, with explanation

PrivyLogic records the equity value and consideration components available in each transaction’s public filing trail. Where a consideration component — such as the PSU settlement level or a convertible’s cash-settlement amount — is not clearly disclosed, the field is left blank rather than estimated. If you are building a precedent set and need to verify the equity value basis for a specific transaction, see the available plans. For enterprise enquiries, contact the team.

Sources

ASC 260 Earnings Per Share — Financial Accounting Standards Board (FASB); accessed September 29, 2026
Schedule 14A — Information Required in Proxy Statement — U.S. Securities and Exchange Commission; accessed September 29, 2026